Predict your next investment

Corporation
INTERNET | Internet Software & Services / Healthcare
veeva.com

See what CB Insights has to offer

Founded Year

2007

Stage

IPO | IPO

Total Raised

$4M

Date of IPO

10/16/2013

Market Cap

44.52B

Stock Price

308.74

Revenue

$0000 

About Veeva Systems

Veeva Systems is a provider of cloud-based software for the life sciences industry.

Veeva Systems Headquarter Location

4280 Hacienda Drive

Pleasanton, California, 94588,

United States

+1 925 452 6500

Latest Veeva Systems News

Veeva : Survey Finds Industry Taking Action to Address Challenges from Rapid Move to Decentralized Trials Amid COVID-19

Oct 14, 2021

10/14/2021 | 08:01am EDT Message : *Required fields PLEASANTON, Calif., Oct. 14, 2021 /PRNewswire/ -- Sponsors and contract research organizations (CROs) are accelerating digital transformation to advance toward patient-centric, paperless, and decentralized trials, according to the Digital Clinical Trials Survey Report conducted by Veeva Systems  (NYSE: VEEV). The new global research shows life sciences companies are taking decisive action to improve operational challenges stemming from the rapid adoption of decentralized technologies during COVID-19, evolving to a study model that expands beyond just decentralization. Today, most sponsors and CROs (87%) use some type of decentralized technology, up 59 percentage points from before the pandemic. With this change, companies added an average of four new applications to their clinical landscape, leading to issues with data collection and stakeholder collaboration and impacting study quality and speed. Findings show that sponsors and CROs are taking action to address these challenges in order to streamline study execution and deliver a better patient and site experience. Nearly all respondents (95%) are working to establish a unified digital trial foundation to improve information sharing and collaboration across stakeholders, better support sites, and eliminate silos through a connected ecosystem. This will bring together patient-facing applications, sponsor and research site operations, and clinical data for end-to-end digital trials that are faster and more efficient. Improving engagement with patients and sites was consistently cited as a critical initiative and a driver for moving to a digital trial model. Major change is happening to address the key challenges with decentralized trials, including lack of site technology adoption (70%) and increased burden for technology-averse patients (50%). Sponsors and CROs are investing in making studies more accessible and convenient to patients by better supporting sites with technology and eliminating paper processes, efforts that can enable seamless trial execution and data flow. "While decentralized approaches have driven positive change in clinical research, more work remains to deliver faster, more cost-effective trials," said Jim Reilly, vice president, Vault R&D at Veeva Systems. "True digital trials will connect the clinical ecosystem and deliver a better trial experience for patients, sites, and sponsors." The full report is available online at veeva.com/DigitalTrialsSurvey . About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit  veeva.com . Research Highlights - Veeva Digital Clinical Trials Survey Report The Veeva Digital Clinical Trials Survey Report examines the opportunities and implications of decentralized approaches on clinical trials by gathering the experiences and opinions of more than 280 clinical leaders worldwide. The report shares views on the industry's progress toward digital trial strategies, lessons learned, and key factors of success. Accelerating Toward Trial Decentralization Models During COVID-19 Most sponsors and CROs (87%) rapidly deployed decentralized trial approaches to minimize disruption, up 59 percentage points from 28% before the pandemic. Within the next 24 months, 95% say their organizations plan to increase the use of decentralized trials. Investment in emerging digital trial technologies will continue, as 32% say they have adopted or plan to adopt eRegulatory / eISF for their sites within the next 12 months, followed by eConsent (31%) and eSource (27%). Rapid Shift to Decentralized Trials Leads to More Operational Challenges Sponsors and CROs added four new function-specific solutions to their existing clinical landscape. Nearly all sponsors and CROs (99%) report significant challenges with decentralized trials. The top challenges with decentralized trials are site technology adoption (70%), internal change management/stakeholder alignment (59%), data protection and privacy (51%), and burden for technology-averse patients (50%). Moving to Digital Trials to Improve Study Quality and Accelerate Clinical Research Nearly all respondents (95%) report having initiatives to address the system and operational challenges introduced by rapidly adopting decentralized approaches. Highlighting the critical importance of reducing site burden, most CROs (66%) and sponsors (53%) are taking steps to offer sites better support with technology. Improving data sharing and collaboration, addressing system interoperability concerns, and eliminating paper processes are key priorities for sponsors and CROs. What Clinical Leaders are Saying About Decentralized Trials "New systems and processes have led to inefficient internal workflows, challenges with collaboration, and getting information in and out of systems." "Decentralized trials introduce more technology, processes, and burden for the site. We need to provide a helping hand, a white-glove approach to help them with efficient execution." "It is essential to evaluate the relative merits of technologies but aim to use fewer applications with better connections between them." Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Veeva Systems

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Veeva Systems in 2 CB Insights research briefs, most recently on Jun 9, 2021.

Expert Collections containing Veeva Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Veeva Systems is included in 3 Expert Collections, including Smart Money VCs (2017-2019).

S

Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

C

Clinical Trials Tech

311 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

M

Medical Devices

66 items

https://mdic.org/membership/our-members/

Veeva Systems Patents

Veeva Systems has filed 53 patents.

The 3 most popular patent topics include:

  • Content management systems
  • Data management
  • Free content management systems
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/21/2018

8/10/2021

Content management systems, Free content management systems, Document management systems, Information technology management, Data management

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/21/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/10/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Content management systems, Free content management systems, Document management systems, Information technology management, Data management

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Veeva Systems Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Veeva Systems Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.